JUN 04, 2021 7:32 AM PDT

Stem Cell Transplants May Treat Patients with Type 2 Diabetes

WRITTEN BY: Annie Lennon

Researchers at the Vinmec Research Institute of Stem Cell and Gene Technology in Hanoi, Vietnam have found that stem cell transplants may benefit some with Type 2 diabetes. 

For the study, the researchers recruited 30 adult patients with various body mass indexes. Each had diabetes from one to 25 years. After administering two infusions of autologous bone marrow stem cells (taken from the patients’ own bodies), the researchers examined the patients again at one-month, three-month, six-month and 12-month follow-ups. 

To measure the success of the treatment, the researchers measured changes in haemoglobin A1c (a measure of average blood sugar levels over the last three months), fasting blood glucose and C-peptide levels (a measure of how much insulin the body makes). 

In the end, they found that patients who had diabetes for less than 10 years and who had a body mass index of less than 23 saw some short term therapeutic effects. 

The data say the researchers, suggests that autologous administration of stromal stem cells could be performed on patients who have had diabetes for less than 10 years and who are not obese. They added that the treatment was nevertheless well-tolerated among all patients. 

"Our patients tolerated the procedure well and showed short-term reductions in their blood glucose levels after the treatment," said Liem Nguyen, lead author of the study. "We also found that some of them were able to temporarily reduce the dosage of their diabetes medications."

Before being able to confirm the effectiveness of their treatment, however, the researchers say that a trial conducted on more people should be conducted. Such a trial, they say, should include people with different histories of Type 2 diabetes, and could help them better understand the mechanism underlying their present results. 

 

Source: EurekAlertSTEM CELLS Translational Medicine

About the Author
  • Science writer with a keen interest in behavioral biology, consciousness medicine and technology. Her current focus is how the interplay of these fields can create meaningful interactions, products and environments.
You May Also Like
MAR 09, 2021
Drug Discovery & Development
Personalized Psychedelic Assisted-Therapy
MAR 09, 2021
Personalized Psychedelic Assisted-Therapy
Psychedelics have long been known for their therapeutic in treating mental health disorders. However, there remains a co ...
APR 01, 2021
Drug Discovery & Development
Injection Treats Childhood Blindness
APR 01, 2021
Injection Treats Childhood Blindness
A patient with a genetic-based childhood blindness has gained vision after receiving an experimental RNA therapeutic tre ...
APR 24, 2021
Drug Discovery & Development
Lithium Treats Intellectual Disabilities in Mice
APR 24, 2021
Lithium Treats Intellectual Disabilities in Mice
Mouse models of Bardet-Biedl Syndrome (BBS) have a challenge with learning as a result of dysfunctional neuronal systems ...
MAY 06, 2021
Drug Discovery & Development
Tweaked Version of Ketamine Could Solve the Opioid Crisis
MAY 06, 2021
Tweaked Version of Ketamine Could Solve the Opioid Crisis
Medications that manage post-operative pain are some of the main entry points to opioid addiction and overdose in the US ...
MAY 31, 2021
Immunology
Engineering Faster, More Agile T Cell Cancer Fighters
MAY 31, 2021
Engineering Faster, More Agile T Cell Cancer Fighters
Cell therapies use engineered T cells extracted from the patient’s own immune system to rally an attack on tumors. ...
JUN 11, 2021
Drug Discovery & Development
Laughing Gas Shows Promise in Rapid Relief of Treatment-Resistant Depression
JUN 11, 2021
Laughing Gas Shows Promise in Rapid Relief of Treatment-Resistant Depression
Researchers led by the University of Chicago Medicine and Washington University have found that low doses of laughing ga ...
Loading Comments...